Site-specific structural characterization of O-glycosylation and identification of phosphorylation sites of recombinant osteopontin

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1854, Issue 6, 2015, Pages 581-591

  Li, Hong ^a   Shen, Huali ^a   Yan, Guoquan ^a   Zhang, Yang ^a   Liu, Mingqi ^a   Fang, Pan ^a   Yu, Hongxiu ^a   Yang, Pengyuan ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Mass spectrometry; O glycosylation; Osteopontin; Phosphorylation; Site specific

Indexed keywords

BOVINE SERUM ALBUMIN; EPITOPE; GLYCAN; GLYCOPEPTIDE; LECTIN; N ACETYLGALACTOSAMINE; OLIGOSACCHARIDE; OSTEOPONTIN; RECOMBINANT PROTEIN; THERMOLYSIN; TRYPSIN;

AMINO ACID SEQUENCE; ARTICLE; DIGESTION; GLYCOSYLATION; HUMAN; HYDROPHILICITY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVERSED PHASE LIQUID CHROMATOGRAPHY; TANDEM MASS SPECTROMETRY; CHEMISTRY; HEK293 CELL LINE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; PEPTIDE MAPPING; PHOSPHORYLATION; PROCEDURES;

CHROMATOGRAPHY, LIQUID; GLYCOSYLATION; HEK293 CELLS; HUMANS; MASS SPECTROMETRY; OSTEOPONTIN; PEPTIDE MAPPING; PHOSPHORYLATION; RECOMBINANT PROTEINS;

EID: 84961291932     PISSN: 15709639     EISSN: 18781454     Source Type: Journal    
DOI: 10.1016/j.bbapap.2014.09.025     Document Type: Article

References (41)

1. S. Ashkar, G.F. Weber, V. Panoutsakopoulou, and M.E. Sanchirico Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity Science 287 2000 860 864
2. S.R. Rittling, and A.F. Chambers Role of osteopontin in tumour progression Br. J. Cancer 90 2004 1877 1881
3. C.M. Giachelli, and S. Steitz Osteopontin: a versatile regulator of inflammation and biomineralization Matrix Biol. 19 2000 615 622
4. J. Sodek, B. Ganss, and M.D. McKee Osteopontin Crit. Rev. Oral Biol. Med. 11 2000 279 303
5. P.Y. Wai, and P.C. Kuo Osteopontin: regulation in tumor metastasis Cancer Metastasis Rev. 27 2008 103 118
6. G.F. Weber The cancer biomarker osteopontin: combination with other markers Cancer Genomics Proteomics 8 2011 263 288
7. K. Yumoto, M. Ishijima, and S.R. Rittling Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice Proc. Natl. Acad. Sci. U. S. A. 99 2002 4556 4561
8. V. Shanmugam, I. Chackalaparampil, G.C. Kundu, and A.B. Mukherjee Altered sialylation of osteopontin prevents its receptor-mediated binding on the surface of oncogenically transformed tsB77 Cells Biochemistry 36 1997 5729 5738
9. A. Cazet, S. Julien, M. Bobowski, and J. Burchell Tumor-associated carbohydrate antigens in breast cancer Breast Cancer Res. 12 2010 204 216
10. A. Minai-Tehrani, S.H. Chang, S.B. Park, and M.H. Cho The O-glycosylation mutant osteopontin alters lung cancer cell growth and migration in vitro and in vivo Int. J. Mol. Med. 32 2013 1137 1149
11. H. Shiraga, W. Min, W.J. VanDusen, and M.D. Clayman Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily Proc. Natl. Acad. Sci. U. S. A. 89 1992 426 430
12. T. Wada, M.D. McKee, S. Steitz, and C.M. Giachelli Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin Circ. Res. 84 1999 166 178
13. Y. Miura, K. Kato, Y. Takegawa, and M. Kurogochi Glycoblotting-assisted O-glycomics: ammonium carbamate allows for highly efficient O-glycan release from glycoproteins Anal. Chem. 82 2010 10021 10029
14. P.H. Jensen, D. Kolarich, and N.H. Packer Mucin-type O-glycosylation - putting the pieces together FEBS J. 277 2010 81 94
15. B. Christensen, M.S. Nielsen, K.F. Haselmann, and T.E. Petersen Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications Biochem. J. 390 2005 285 292
16. B. Christensen, T.E. Petersen, and E.S. Sørensen Post-translational modification and proteolytic processing of urinary osteopontin Biochem. J. 411 2008 53 61
17. G. Zauner, M. Hoffmann, E. Rapp, and C.A. Koeleman Glycoproteomic analysis of human fibrinogen reveals novel regions of O-glycosylation J. Proteome Res. 11 2012 5804 5814
18. A. Halim, G. Brinkmalm, U. Rüetschi, and A. Westman-Brinkmalm Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid beta-peptides in human cerebrospinal fluid Proc. Natl. Acad. Sci. U. S. A. 108 2011 11848 11853
19. H. Han, M. Stapels, W. Ying, and Y. Yu Comprehensive characterization of the N-glycosylation status of CD44s by use of multiple mass spectrometry-based techniques Anal. Bioanal. Chem. 404 2012 373 388
20. K. Masuda, N. Takahashi, Y. Tsukamoto, and H. Honma N-glycan structures of an osteopontin from human bone Biochem. Biophys. Res. Commun. 268 2000 814 817
21. V. Takafuji, M. Forgues, E. Unsworth, P. Goldsmith, and X.W. Wang An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma Oncogene 26 2007 6361 6371
22. X. Luo, M.K. Ruhland, E. Pazolli, A.C. Lind, and S.A. Stewart Osteopontin stimulates preneoplastic cellular proliferation through activation of the MAPK pathway Mol. Cancer Res. 9 2011 1018 1029
23. M.L. Shinohara, L. Lu, J. Bu, M.B. Werneck, K.S. Kobayashi, L.H. Glimcher, and H. Cantor Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells Nat. Immunol. 7 2006 498 506
24. K.P. Doyle, T. Yang, N.S. Lessov, T.M. Ciesielski, S.L. Stevens, R.P. Simon, J.S. King, and M.P. Stenzel-Poore Nasal administration of osteopontin peptide mimetics confers neuroprotection in stroke J. Cereb. Blood Flow Metab. 28 2008 1235 1248
25. P. Beltrao, P. Bork, N.J. Krogan, and V. van Noort Evolution and functional cross-talk of protein post-translational modifications Mol. Syst. Biol. 9 2013 714
26. A.M. Butt, D. Feng, M. Idrees, Y. Tong, and J. Lu Computational Identification and modeling of crosstalk between phosphorylation, O-β-glycosylation and methylation of FoxO3 and implications for cancer therapeutics Int. J. Mol. Sci. 13 2012 2918 2938
27. H. Wang, H. Li, W. Zhang, and L. Wei Multiplex profiling of glycoproteins using a novel bead-based lectin array Proteomics 1 2014 78 86
28. Y. Wada, M. Tajiri, and S. Yoshida Hydrophilic affinity isolation and MALDI multiple-stage tandem mass spectrometry of glycopeptides for glycoproteomics Anal. Chem. 76 2004 6560 6565
29. M.Q. Liu, Y. Zhang, Y.H. Chen, and G.Q. Yan An efficient and accurate glycopeptide identification pipeline for high-throughput site-specific N-glycosylation analysis J. Proteome Res. 13 2014 3121 3129
30. T. Taus, T. Köcher, P. Pichler, and C. Paschke Universal and confident phosphorylation site localization using phosphoRS J. Proteome Res. 10 2011 5354 5362
31. J. Hirabayashi, M. Yamada, A. Kuno, and H. Tateno Lectin microarrays: concept, principle and application Chem. Soc. Rev. 42 2013 4443 4458
32. Y.H. Chen, M.Q. Liu, G.Q. Yan, and H.J. Lu One-pipeline approach achieving glycoprotein identification and obtaining intact glycopeptide information by tandem mass spectrometry Mol. BioSyst. 6 2010 2417 2422
33. P.V. Hornbeck, I. Chabra, J.M. Kornhauser, and E. Skrzypek PhosphoSite: a bioinformatics resource dedicated to physiological protein phosphorylation Proteomics 4 2004 1551 1561
34. M. Keykhosravani, A. Doherty-Kirby, C.J. Zhang, and D. Brewer Comprehensive identification of post-translational modifications of rat bone osteopontin by mass spectrometry Biochemistry 44 2005 6990 7003
35. M. Lasa, P.L. Chang, C.W. Prince, and L.A. Pinna Phosphorylation of osteopontin by Golgi apparatus casein kinase Biochem. Biophys. Res. Commun. 240 1997 602 605
36. H. Ito, A. Kuno, H. Sawaki, and M. Sogabe Strategy for glycoproteomics: identification of glyco-alteration using multiple glycan profiling tools J. Proteome Res. 8 2009 1358 1367
37. P.H. Anborgh, J.C. Mutrie, A.B. Tuck, and A.F. Chambers Pre- and post-translational regulation of osteopontin in cancer J. Cell Commun. Signal 5 2011 111 122
38. H. Rangaswami, A. Bulbule, and G.C. Kundu Osteopontin: role in cell signaling and cancer progression Trends Cell Biol. 16 2006 79 87
39. N.M. Varki, and A. Varki Diversity in cell surface sialic acid presentations: implications for biology and disease Lab. Investig. 87 2007 851 857
40. C. Robbe-Masselot, A. Herrmann, E. Maes, and I. Carlstedt Expression of a core 3 disialyl-Le(x) hexasaccharide in human colorectal cancers: a potential marker of malignant transformation in colon J. Proteome Res. 8 2009 702 711
41. B. Ma, J.L. Simala-Grant, and D.E. Taylor Fucosylation in Prokaryotes and Eukaryotes 16 2006 158 184